Discovery and Validation of a Series of Aryl Sulfonamides as Selective Inhibitors of Tissue-Nonspecific Alkaline Phosphatase (TNAP)
- 12 October 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (21), 6919-6925
- https://doi.org/10.1021/jm900383s
Abstract
We report the characterization and optimization of drug-like small molecule inhibitors of tissue-nonspecific alkaline phosphatase (TNAP), an enzyme critical for the regulation of extracellular matrix calcification during bone formation and growth. High-throughput screening (HTS) of a small molecule library led to the identification of arylsulfonamides as potent and selective inhibitors of TNAP. Critical structural requirements for activity were determined, and the compounds were subsequently profiled for in vitro activity and bioavailability parameters including metabolic stability and permeability. The plasma levels following subcutaneous administration of a member of the lead series in rat was determined, demonstrating the potential of these TNAP inhibitors as systemically active therapeutic agents to target various diseases involving soft tissue calcification. A representative member of the series was also characterized in mechanistic and kinetic studies.Keywords
This publication has 15 references indexed in Scilit:
- Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: Potential mechanism for uremic vascular calcificationKidney International, 2008
- Novel Inhibitors of Alkaline Phosphatase Suppress Vascular Smooth Muscle Cell CalcificationJournal of Bone and Mineral Research, 2007
- Pyrophosphate Inhibits Mineralization of Osteoblast Cultures by Binding to Mineral, Up-regulating Osteopontin, and Inhibiting Alkaline Phosphatase ActivityJournal of Biological Chemistry, 2007
- Vascular calcification in chronic kidney diseaseJournal of Bone and Mineral Metabolism, 2006
- Mammalian Alkaline PhosphatasesPublished by Wiley ,2006
- Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to boneGenes & Development, 2005
- Residues Determining the Binding Specificity of Uncompetitive Inhibitors to Tissue-Nonspecific Alkaline PhosphataseJournal of Bone and Mineral Research, 2004
- Concerted Regulation of Inorganic Pyrophosphate and Osteopontin by Akp2, Enpp1, and AnkThe American Journal of Pathology, 2004
- Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralizationProceedings of the National Academy of Sciences of the United States of America, 2002
- Inorganic pyrophosphate generation and disposition in pathophysiologyAmerican Journal of Physiology-Cell Physiology, 2001